Kiora Payables Turnover from 2010 to 2024

KPRX Stock  USD 3.32  0.05  1.48%   
Kiora Pharmaceuticals Payables Turnover yearly trend continues to be fairly stable with very little volatility. Payables Turnover is likely to outpace its year average in 2024. Payables Turnover is a liquidity ratio that shows how quickly Kiora Pharmaceuticals pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
19.52408126
Current Value
20.63
Quarterly Volatility
32.38672682
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Kiora Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiora Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 84.2 K, Selling General Administrative of 4.8 M or Other Operating Expenses of 10.3 M, as well as many indicators such as Price To Sales Ratio of 16 K, Dividend Yield of 0.0 or PTB Ratio of 0.43. Kiora financial statements analysis is a perfect complement when working with Kiora Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Kiora Pharmaceuticals Correlation against competitors.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.

Latest Kiora Pharmaceuticals' Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of Kiora Pharmaceuticals over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Kiora Pharmaceuticals' Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kiora Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Pretty Stable
   Payables Turnover   
       Timeline  

Kiora Payables Turnover Regression Statistics

Arithmetic Mean12.62
Geometric Mean0.18
Coefficient Of Variation256.56
Mean Deviation17.45
Median0.13
Standard Deviation32.39
Sample Variance1,049
Range127
R-Value0.19
Mean Square Error1,088
R-Squared0.04
Significance0.49
Slope1.39
Total Sum of Squares14,685

Kiora Payables Turnover History

2024 20.63
2023 19.52
2022 0.13
2021 1.41
2020 0.46
2019 0.0233
2018 126.56

About Kiora Pharmaceuticals Financial Statements

Kiora Pharmaceuticals investors use historical fundamental indicators, such as Kiora Pharmaceuticals' Payables Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kiora Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Payables Turnover 19.52  20.63 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Kiora Stock Analysis

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.